Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmut Muslumanoglu

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
World Journal of Surgical Oncology|October 22, 2022
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancerBaran Mollavelioglu, Esin Cetin Aktas, Neslihan Cabioglu, et al.
Frontiers in Medicine|October 20, 2023
Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacyNeslihan Cabioglu, Cihan Uras, Halime Mutlu, et al.
Neoplasma|June 7, 2021
Differential Expression of Novel Immune Checkpoint Receptors on Tumor Infiltrating Lymphocytes in Patients with Locally Advanced Breast Cancer after Neoadjuvant ChemotherapyAykhan Abbasov, Esin Aktas Cetin, Neslihan Cabioglu, et al.
Cell Biology International|November 15, 2022
Ozone therapy restores immune dysfunction in refractory idiopathic granulomatous mastitis as a novel potential therapeutic approachNeslihan Cabioglu, Esin Cetin Aktas, Selman Emiroglu, et al.
Oncology|September 14, 2011
Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapySerkan Keskin, Mahmut Muslumanoglu, Pinar Saip, et al.
Medicine|December 31, 2015
Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to TreatmentAdnan Aydiner, Fatma Sen, Makbule Tambas, et al.
Cancers|July 13, 2024
New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast CancerNeslihan Cabioglu, Semen Onder, Hüseyin Karatay, et al.
Diagnostics (Basel, Switzerland)|March 28, 2026
Ductoscopy Facilitates Surgical Decision-Making in Management of Patients with Pathological Nipple DischargeVusal Aliyev, Zeliha Turkyılmaz, Enver Özkurt, et al.
Frontiers in Oncology|July 31, 2023
Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancerNeslihan Cabioglu, Aysel Bayram, Selman Emiroglu, et al.
Frontiers in Medicine|July 24, 2023
Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitisNeslihan Cabioglu, Didem Can Trabulus, Selman Emiroglu, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
World Journal of Surgical Oncology|October 22, 2022
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancerBaran Mollavelioglu, Esin Cetin Aktas, Neslihan Cabioglu, et al.
Frontiers in Medicine|October 20, 2023
Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacyNeslihan Cabioglu, Cihan Uras, Halime Mutlu, et al.
Neoplasma|June 7, 2021
Differential Expression of Novel Immune Checkpoint Receptors on Tumor Infiltrating Lymphocytes in Patients with Locally Advanced Breast Cancer after Neoadjuvant ChemotherapyAykhan Abbasov, Esin Aktas Cetin, Neslihan Cabioglu, et al.
Cell Biology International|November 15, 2022
Ozone therapy restores immune dysfunction in refractory idiopathic granulomatous mastitis as a novel potential therapeutic approachNeslihan Cabioglu, Esin Cetin Aktas, Selman Emiroglu, et al.
Oncology|September 14, 2011
Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapySerkan Keskin, Mahmut Muslumanoglu, Pinar Saip, et al.
Medicine|December 31, 2015
Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to TreatmentAdnan Aydiner, Fatma Sen, Makbule Tambas, et al.
Cancers|July 13, 2024
New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast CancerNeslihan Cabioglu, Semen Onder, Hüseyin Karatay, et al.
Diagnostics (Basel, Switzerland)|March 28, 2026
Ductoscopy Facilitates Surgical Decision-Making in Management of Patients with Pathological Nipple DischargeVusal Aliyev, Zeliha Turkyılmaz, Enver Özkurt, et al.
Frontiers in Oncology|July 31, 2023
Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancerNeslihan Cabioglu, Aysel Bayram, Selman Emiroglu, et al.
Frontiers in Medicine|July 24, 2023
Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitisNeslihan Cabioglu, Didem Can Trabulus, Selman Emiroglu, et al.
Pageof 10